# BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

> **NCT07511517** · — · ACTIVE_NOT_RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Non-Muscle Invasive Bladder Neoplasms
- Urinary Bladder Neoplasms
- Carcinoma, Transitional Cell, Bladder

## Interventions

- **DIAGNOSTIC_TEST:** BladMetrix urine test

## Key facts

- **NCT ID:** NCT07511517
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-10-03
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511517, "BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07511517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*